Literature DB >> 33546426

Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone.

Parinbhai Shah1,2, Benjamin Goodyear1,2, Nirali Dholaria1,2, Vinam Puri1,2, Bozena Michniak-Kohn1,2.   

Abstract

Psoriasis is a chronic autoimmune skin disease impacting the population globally. Pharmaceutical products developed to combat this condition commonly used in clinical settings are IV bolus or oral drug delivery routes. There are some major challenges for effectively developing new dosage forms for topical use: API physicochemical nature, the severity of the disease state, and low bioavailability present challenges for pharmaceutical product developers. For non-severe cases of psoriasis, topical drug delivery systems may be preferred or used in conjunction with oral or parenteral therapy to address local symptoms. Elastic vesicular systems, termed "niosomes", are promising drug delivery vehicles developed to achieve improved drug delivery into biological membranes. This study aimed to effectively incorporate a corticosteroid into the niosomes for improving the drug bioavailability of desoximetasone, used to treat skin conditions via topical delivery. Niosomes characterization measurements were drug content, pH, spreadability, specific gravity, content uniformity, rheology, and physicochemical properties. Formulations used a topical gelling agent, Carbomer 980 to test for in vitro skin permeation testing (IVPT) and accelerated stability studies. The developed niosomal test gel provided approximately 93.03 ± 0.23% to 101.84 ± 0.11% drug content with yield stresses ranging from 16.12 to 225.54 Pa. The permeated amount of desoximetasone from the niosomal gel after 24 h was 9.75 ± 0.44 µg/cm2 compared to 24.22 ± 4.29 µg/cm2 released from the reference gel tested. Furthermore, a drug retention study compared the test gel to a reference gel, demonstrating that the skin retained 30.88 ng/mg of desoximetasone while the reference product retained 26.01 ng/mg. A controlled drug release profile was obtained with a niosomal formulation containing desoximetasone for use in a topical gel formulation showing promise for potential use to treat skin diseases like psoriasis.

Entities:  

Keywords:  allergic reactions; controlled drug delivery; corticosteroid drug delivery; desoximetasone; eczema; niosomal gel formulation; psoriasis; skin permeation; topical drug delivery

Mesh:

Substances:

Year:  2021        PMID: 33546426      PMCID: PMC7913730          DOI: 10.3390/ijms22041535

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  38 in total

Review 1.  Proteins, polysaccharides, and their complexes used as stabilizers for emulsions: alternatives to synthetic surfactants in the pharmaceutical field?

Authors:  Eléonore Bouyer; Ghozlene Mekhloufi; Véronique Rosilio; Jean-Louis Grossiord; Florence Agnely
Journal:  Int J Pharm       Date:  2012-07-01       Impact factor: 5.875

Review 2.  Topical delivery for the treatment of psoriasis.

Authors:  Amitava Mitra; Yunhui Wu
Journal:  Expert Opin Drug Deliv       Date:  2010-08       Impact factor: 6.648

Review 3.  Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.

Authors:  Mahfoozur Rahman; Sohail Akhter; Javed Ahmad; Mohammad Zaki Ahmad; Sarwar Beg; Farhan Jalees Ahmad
Journal:  Expert Opin Drug Deliv       Date:  2014-12-02       Impact factor: 6.648

4.  1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987.

Authors:  Nicholas A Peppas
Journal:  J Control Release       Date:  2014-09-28       Impact factor: 9.776

Review 5.  Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products.

Authors:  Rong-Kun Chang; Andre Raw; Robert Lionberger; Lawrence Yu
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

6.  Topical drug classification.

Authors:  Lucinda Buhse; Richard Kolinski; Benjamin Westenberger; Anna Wokovich; John Spencer; Chi Wan Chen; Saleh Turujman; Mamta Gautam-Basak; Gil Jong Kang; Arthur Kibbe; Brian Heintzelman; Eric Wolfgang
Journal:  Int J Pharm       Date:  2005-05-13       Impact factor: 5.875

7.  Development and characterization of niosomal gel for topical delivery of benzoyl peroxide.

Authors:  Gagan Goyal; Tarun Garg; Basant Malik; Gaurav Chauhan; Goutam Rath; Amit K Goyal
Journal:  Drug Deliv       Date:  2013-11-20       Impact factor: 6.419

8.  Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis.

Authors:  A Wolkerstorfer; M A Strobos; E J Glazenburg; P G Mulder; A P Oranje
Journal:  J Am Acad Dermatol       Date:  1998-08       Impact factor: 11.527

9.  Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity.

Authors:  Ankush Gupta; Sima Singh; Niranjan G Kotla; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2014-12-24

10.  Evaluations of Quality by Design (QbD) Elements Impact for Developing Niosomes as a Promising Topical Drug Delivery Platform.

Authors:  Parinbhai Shah; Benjamin Goodyear; Anika Haq; Vinam Puri; Bozena Michniak-Kohn
Journal:  Pharmaceutics       Date:  2020-03-09       Impact factor: 6.321

View more
  2 in total

Review 1.  Gemini and Bicephalous Surfactants: A Review on Their Synthesis, Micelle Formation, and Uses.

Authors:  Lluvia Guerrero-Hernández; Héctor Iván Meléndez-Ortiz; Gladis Y Cortez-Mazatan; Sandra Vaillant-Sánchez; René D Peralta-Rodríguez
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

2.  Dextrin-Based Nanohydrogels for Rokitamycin Prolonged Topical Delivery.

Authors:  Maria Tannous; Silvia Lucia Appleton; Gjylije Hoti; Fabrizio Caldera; Monica Argenziano; Yousef Khazaei Monfared; Adrián Matencio; Francesco Trotta; Roberta Cavalli
Journal:  Gels       Date:  2022-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.